Gubra A/S Total Liabilities
Gubra A/S total liabilities. Based on the latest financial reports, Gubra A/S (GUBRA) has total liabilities worth Dkr173.94 Million DKK (≈ $27.21 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check GUBRA asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Gubra A/S (2019–2025)
Total liabilities of Gubra A/S from 2019 to 2025. This chart illustrates how Gubra A/S's total liabilities have evolved over time, based on quarterly financial data.
Gubra A/S Competitors by Total Liabilities
The table below lists competitors of Gubra A/S ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hextar Global Bhd
KLSE:5151
|
Malaysia | RM562.93 Million |
|
Hangzhou Star Shuaier Electric Appliance Co Ltd
SHE:002860
|
China | CN¥1.51 Billion |
|
Dalian Sunasia Tourism Holding Co Ltd
SHG:600593
|
China | CN¥1.63 Billion |
|
Mid Penn Bancorp
NASDAQ:MPB
|
USA | $5.32 Billion |
|
Haima Automobile Group Co Ltd
SHE:000572
|
China | CN¥2.45 Billion |
|
Hite Jinro
KO:000080
|
Korea | ₩2.19 Trillion |
|
Peakstone Realty Trust
NYSE:PKST
|
USA | $1.21 Billion |
|
Jiangyin Electrical Alloy Co Ltd
SHE:300697
|
China | CN¥1.34 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Gubra A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Gubra A/S balance sheet assets.
Liquidity & Leverage Metrics
Gubra A/S Total Liabilities Ratios Explained
Gubra A/S total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Gubra A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Gubra A/S (2019–2025)
The table below shows the annual total liabilities of Gubra A/S from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Dkr173.94 Million ≈ $27.21 Million |
+7.43% |
| 2024-12-31 | Dkr161.91 Million ≈ $25.33 Million |
+11.19% |
| 2023-12-31 | Dkr145.62 Million ≈ $22.78 Million |
-5.87% |
| 2022-12-31 | Dkr154.69 Million ≈ $24.20 Million |
+2.68% |
| 2021-12-31 | Dkr150.66 Million ≈ $23.57 Million |
+30.82% |
| 2020-12-31 | Dkr115.17 Million ≈ $18.02 Million |
+8.28% |
| 2019-12-31 | Dkr106.36 Million ≈ $16.64 Million |
-- |
About Gubra A/S
Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green. The company offers preclinical contract research and development services within metabolic and fibrotic diseases for th… Read more